The Indiana-based company received $150,000 from the NSF’s Small Business Innovation Research’s phase I grant and an additional $50,000 from Elevate Ventures in partnership with the Indiana Economic Development Corp.
Sintact, founded by PhDs Erik Robinson and Gali Baler in 2013, plans to use the funds to continue ongoing testing and development of a film designed to separate and protect internal organs from scars or scar-related defects after surgeries. The company graduated from Health Wildcatters last year.
““It’s wonderful to see Sintact making such great progress since the program,” Health Wildcatters CEO Hubert Zajicek said in a released statement. “They have all the elements for success, so it’s exciting to watch all those elements come together as they get closer to bringing their technology to the patients who can benefit from it.”
The phase I grant from the National Science Foundation is designed to help companies with their proof-of-concept. It can then be followed by a development grant of $750,000. Phase I ends Dec. 31, at which time Sintact will report its results for consideration for additional funding.
Sintact plans to conduct a three-month animal study during its initial phase.
Danielle covers technology and startups for the Dallas Business Journal. Subscribe to our new TechFlash email newsletter.